Comparison between intravenous lignocaine and nebulization with lignocaine in suppressing response to laryngoscopy and intubatio
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/02/063279
- Lead Sponsor
- Dr Shipra Chnadra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. patient giving consent
2. all patients aged 18-45yrs
3. ASA grade 1&2
4. both genders
5.hemodynamically stable patients
6. patients undergoing elective surgical procedures under GA
7. patient not receiving any vasoactive drugs.
Exclusion Criteria
1. Patient refusal for giving consent
2. Patient who already received lignocaine by any route.
3. Hypersensitivity to lignocaine.
4. History of convulsions.
5. Patient receiving vasoactive drug support.
6. Patient on mechanical ventilation with endotracheal or tracheostomy tube.
7. H/O COPD, cardiovascular disease, psychiatric disorders and liver disorders.
8. Patients with anticipated difficult airway.
9. Patients having history of laryngeal, tracheal surgery or any pathology.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method